Search filters

List of works by Andrew M Brunner

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.

scientific article published on 9 November 2017

Allogeneic hematopoietic cell transplantation following the use of hypomethylating agents among patients with relapsed or refractory AML: Findings from an international retrospective study.

scientific article published on 9 April 2018

Genomics in childhood acute myeloid leukemia comes of age.

scientific article published in January 2018

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

scientific article published on 01 April 2018

Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes

scientific article published on 28 August 2018

Low Clinical Trial Accrual of Patients With Myelodysplastic Syndromes: Causes and Potential Solutions

scientific article published on 05 October 2018

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

scientific article published on 04 March 2020

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

scientific article published on 02 July 2018

Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

scientific article published on 18 October 2017